KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables Refunds
Ratios

Astrana Health (ASTH) Receivables Refunds (2021 - 2025)

Astrana Health's Receivables Refunds history spans 4 years, with the latest figure at $19.3 million for Q4 2024.

  • For Q4 2024, Receivables Refunds rose 81.25% year-over-year to $19.3 million; the TTM value through Dec 2024 reached $19.3 million, up 81.25%, while the annual FY2024 figure was $19.3 million, 81.25% up from the prior year.
  • Receivables Refunds for Q4 2024 was $19.3 million at Astrana Health, up from $16.2 million in the prior quarter.
  • Across five years, Receivables Refunds topped out at $22.0 million in Q2 2024 and bottomed at $1.4 million in Q2 2021.
  • The 4-year median for Receivables Refunds is $12.2 million (2022), against an average of $12.1 million.
  • The largest annual shift saw Receivables Refunds surged 786.33% in 2022 before it rose 24.21% in 2023.
  • A 4-year view of Receivables Refunds shows it stood at $5.7 million in 2021, then soared by 51.11% to $8.6 million in 2022, then increased by 24.21% to $10.7 million in 2023, then soared by 81.25% to $19.3 million in 2024.
  • Per Business Quant, the three most recent readings for ASTH's Receivables Refunds are $19.3 million (Q4 2024), $16.2 million (Q3 2024), and $22.0 million (Q2 2024).